Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term parasite proteins in Plasmodium falciparum digestive vacuole and cytosol refers to a broad collection of molecular entities rather than a single therapeutic target. The digestive vacuole (DV) is a specialized acidic organelle where Plasmodium falciparum degrades host hemoglobin to acquire essential nutrients, a process mediated by proteases such as plasmepsins and falcipains (Goldberg, 2005, PMID: 15813510). This degradation releases toxic free heme, which the parasite must sequester into inert hemozoin crystals via heme detoxification proteins (Egan, 2008, PMID: 18514313). The cytosol contains the parasite's metabolic machinery, including enzymes for glycolysis, folate biosynthesis, and protein translation (Cowman et al., 2012, PMID: 22960356). Many antimalarial drugs, such as chloroquine and artemisinin, target specific processes within these compartments, such as heme biocrystallization or calcium homeostasis (Tilley et al., 2016, PMID: 26711511). However, because this designation encompasses hundreds of distinct proteins with diverse functions, it is considered an overly broad category for specific drug-target interaction modeling.
Multiple mechanisms including inhibition of heme biocrystallization, inhibition of hemoglobin-degrading proteases, disruption of parasite calcium homeostasis, and inhibition of folate synthesis.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plasmodium falciparum digestive vacuole and cytosolic proteins.